One of the most common questions we receive regarding FSVP is whether there are limits for parent companies in their ability to assist US-Based subsidiaries with FSVP compliance. This post seeks to answer this question using the preamble to FDA’s FSVP Final Rule, the CFR, current FDA FSVP guidance and a recent response from FDA’s Technical Assistance Network (TAN).